Ledyard National Bank Has $1.97 Million Stock Holdings in Sanofi (NASDAQ:SNY)

Ledyard National Bank decreased its holdings in Sanofi (NASDAQ:SNY) by 5.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 40,494 shares of the company’s stock after selling 2,490 shares during the quarter. Ledyard National Bank’s holdings in Sanofi were worth $1,968,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Rise Advisors LLC raised its stake in shares of Sanofi by 98.4% in the 4th quarter. Rise Advisors LLC now owns 506 shares of the company’s stock valued at $25,000 after buying an additional 251 shares in the last quarter. Salem Investment Counselors Inc. bought a new stake in shares of Sanofi in the 4th quarter worth about $27,000. Venturi Wealth Management LLC grew its holdings in shares of Sanofi by 163.5% in the 4th quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock worth $27,000 after purchasing an additional 332 shares during the last quarter. Frazier Financial Advisors LLC bought a new stake in shares of Sanofi in the 4th quarter worth about $28,000. Finally, Larson Financial Group LLC grew its holdings in shares of Sanofi by 480.8% in the 1st quarter. Larson Financial Group LLC now owns 604 shares of the company’s stock worth $29,000 after purchasing an additional 500 shares during the last quarter. Institutional investors and hedge funds own 10.04% of the company’s stock.

Sanofi Price Performance

Shares of SNY traded up $0.15 during trading hours on Thursday, hitting $50.36. The stock had a trading volume of 2,758,675 shares, compared to its average volume of 2,141,385. The company’s fifty day moving average is $48.95 and its two-hundred day moving average is $48.68. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.27 and a quick ratio of 0.87. Sanofi has a 52 week low of $42.63 and a 52 week high of $55.72. The stock has a market capitalization of $127.55 billion, a price-to-earnings ratio of 25.31, a P/E/G ratio of 1.55 and a beta of 0.59.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings data on Thursday, April 25th. The company reported $0.96 EPS for the quarter, hitting analysts’ consensus estimates of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The firm had revenue of $11.36 billion for the quarter, compared to analyst estimates of $11.75 billion. On average, analysts anticipate that Sanofi will post 4.14 EPS for the current year.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.